Skip to content
Triangle logo TriangleGet started
← Full study record

NCT03096782 · OUTCOME

Disease-free Survival

Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or Lymphoma · Source last updated 2023-10-11

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
COUNT_OF_PARTICIPANTS
Unit
Participants
Interval / dispersion
Not reported
Time frame
Up to12 months

What was measured

Number of participants that were in remission post transplant.

Groups in this outcome

Chemotherapy Plus Cord Blood Transplant

GVHD PROPHYLAXIS: All patients receive mycofenolate mofetil IV over 2 hours or PO BID on days -3 with a taper beginning on day 100 in the absence of GVHD, tacrolimus IV or PO starting on day -2 for 6 months in the absence of GVHD, and filgrastim-sndz SC QD starting on day 0 until white blood count begins to recover. Anti-Thymocyte Globulin: Given IV Busulfan: Given IV Clofarabine: Given IV Filgrastim-sndz: Given SC Fludarabine: Given IV Mycophenolate Mofetil: Given IV or PO Rituximab: Given IV Tacrolimus: Given IV Total-Body Irradiation: Undergo total body irradiation Umbilical Cord Blood Transplantation: Undergo cord blood transplant

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Chemotherapy Plus Cord Blood Transplant6

Reported measurements

Complete Remission at 30 days
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Chemotherapy Plus Cord Blood Transplant6Not reportedNot reportedNot reportedNot reported
Complete Remission at 12 months
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Chemotherapy Plus Cord Blood Transplant4Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        6
    title
    Complete Remission at 30 days
  2. categories
    1. measurements
      1. group Id
        OG000
        value
        4
    title
    Complete Remission at 12 months
denoms
  1. counts
    1. group Id
      OG000
      value
      6
    units
    Participants
description
Number of participants that were in remission post transplant.
groups
  1. description
    GVHD PROPHYLAXIS: All patients receive mycofenolate mofetil IV over 2 hours or PO BID on days -3 with a taper beginning on day 100 in the absence of GVHD, tacrolimus IV or PO starting on day -2 for 6 months in the absence of GVHD, and filgrastim-sndz SC QD starting on day 0 until white blood count begins to recover. Anti-Thymocyte Globulin: Given IV Busulfan: Given IV Clofarabine: Given IV Filgrastim-sndz: Given SC Fludarabine: Given IV Mycophenolate Mofetil: Given IV or PO Rituximab: Given IV Tacrolimus: Given IV Total-Body Irradiation: Undergo total body irradiation Umbilical Cord Blood Transplantation: Undergo cord blood transplant
    id
    OG000
    title
    Chemotherapy Plus Cord Blood Transplant
param Type
COUNT_OF_PARTICIPANTS
reporting Status
POSTED
time Frame
Up to12 months
title
Disease-free Survival
type
SECONDARY
unit Of Measure
Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice